Proceuticals Private Label by TiZO non-tinted foaming mineral sunscreen by is a Otc medication manufactured, distributed, or labeled by Fallien Cosmeceuticals, Ltd, Tri-Pac Inc, Custom Analytics LLC. Drug facts, warnings, and ingredients follow.
DIRECTIONS:
Shake well before using.
Press nozzle carefully during first use
Apply liberally 15 minutes before sun exposure.
Reapply:
After 40 minutes of swimming or sweating
Immediately after towel drying
At least every 2 hours
Children under 6 months: Ask a doctor
Sun Protection Measures: Spending time in the sun increases your risk of
skin cancer and early skin aging. To decrease this risk, regularly use a
sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun
protection measures including:
Limit time in the sun, especially from 10 am -2 pm
Wear long-sleeved shirts, pants, hats, and sunglasses
INACTIVE INGREDIENTS:Butyloctyl Salicylate, C12-15 Alkyl Benzoate, Caprylhydroxamic Acid, Caprylyl
Glycol, Cellulose Gum, Ceteareth-20, Cetearyl Alcohol, Citric Acid, Disodium
EDTA, Glycereth-26, Glycerin, Glyceryl Stearate, Isododecane, Isohexadecane,
Methyl Methacrylate Crosspolymer, Microcrystalline Cellulose, Octyldodecyl
Erucate, Octyldodecyl Neopentanoate, Polymethyl Methacrylate, Polysorbate
80, Trans-1,3,3,3-Tetrafluoropropene, Tricontanyl PVP, Triethoxycaprylylsilane,
Water
PROCEUTICALS PRIVATE LABEL BY TIZO NON-TINTED FOAMING MINERAL SUNSCREEN
titanium dioxide, zinc oxide aerosol, foam |
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Fallien Cosmeceuticals, Ltd (958388357) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Tri-Pac Inc | 020844956 | manufacture(58892-211) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Custom Analytics LLC | 144949372 | analysis(58892-211) |